Global Exporter & Bulk Supplier of Doxlieva 50mg Injection

🌍 Introduction

Are you searching for a certified and highly efficient global exporter for Doxlieva 50mg Injection? At Ernest Oncology (the premier oncology division of Ernest Pharmaceutical Pvt. Ltd.), we are leaders in the international distribution of high-quality cytotoxic agents. We provide seamless, temperature-controlled supply chain solutions for Doxorubicin 50mg injections to leading hospitals, cancer centers, and pharmaceutical wholesalers in the USA, UK, Australia, and South Africa.

🔬 1. Product Overview: Doxlieva 50mg Injection

Doxlieva 50mg Injection contains Doxorubicin Hydrochloride, a potent anthracycline antibiotic that has been a cornerstone of chemotherapy for decades.

• Composition: Doxorubicin Hydrochloride 50mg (as a sterile lyophilized powder or solution)

• Therapeutic Class: Antineoplastic / Anthracycline Antibiotic

• Formulation Type: Single-dose vial for Intravenous (IV) infusion.

• Storage: Store under refrigeration ($2^\circ\text{C}$ to $8^\circ\text{C}$). Protect from light.

⚙️ 2. Mechanism of Action

Doxlieva works through a multi-faceted approach to destroy malignant cells:

• Intercalation: The molecule slides between DNA base pairs, causing structural damage.

• Topoisomerase II Inhibition: It inhibits the enzyme Topoisomerase II, preventing the DNA from resealing during replication, which leads to DNA strand breaks.

• Free Radical Generation: It produces reactive oxygen species (free radicals) that damage cellular membranes and proteins.

• Apoptosis: These combined actions halt cell division and trigger programmed cell death.

🏥 3. Therapeutic Indications

Doxlieva 50mg Injection is indicated for a wide range of cancers, making it a "broad-spectrum" chemotherapy agent:

• Breast Cancer: A standard component of adjuvant and metastatic treatment regimens.

• Hematological Malignancies: Used in the treatment of Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Hodgkin’s and Non-Hodgkin’s Lymphomas.

• Sarcomas: Effective against Osteosarcoma and Soft Tissue Sarcoma.

• Solid Tumors: Used for Ovarian, Bladder, Thyroid, and Gastric cancers.

⚠️ 4. Administration & Safety Guidelines

• Professional Administration: Must only be administered by qualified oncology medical staff via Intravenous (IV) infusion.

• Vesicant Risk: Doxorubicin is a potent vesicant. Proper catheter placement is vital to prevent extravasation and severe tissue damage.

• Cardiotoxicity Monitoring: Cumulative lifetime doses must be tracked carefully due to the risk of irreversible heart muscle damage.

• Hematologic Monitoring: Patients require regular blood tests to monitor for myelosuppression (low blood counts).